The Klinique Medical Clinic PCL (BKK:KLINIQ)
Thailand · Delayed Price · Currency is THB 23.70
+0.30 (1.28%)
At close: Feb 10, 2026
BKK:KLINIQ Income Statement
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,386 | 2,983 | 2,285 | 1,639 | 949.93 | 1,001 |
| 3,386 | 2,983 | 2,285 | 1,639 | 949.93 | 1,001 | |
Revenue Growth (YoY) | 21.62% | 30.55% | 39.41% | 72.54% | -5.06% | 53.70% |
Cost of Revenue | 1,652 | 1,440 | 1,050 | 716.07 | 391.16 | 406.55 |
Gross Profit | 1,734 | 1,543 | 1,235 | 922.97 | 558.77 | 594 |
Selling, General & Admin | 1,287 | 1,154 | 903.07 | 674.28 | 407.68 | 431.13 |
Other Operating Expenses | -10.4 | -9.54 | -13.2 | -7.06 | -2.15 | -6.07 |
Operating Expenses | 1,277 | 1,144 | 889.88 | 667.22 | 405.53 | 425.06 |
Operating Income | 457.54 | 398.58 | 345.16 | 255.75 | 153.24 | 168.94 |
Interest Expense | -25.72 | -23.9 | -15.1 | -10.66 | -4.32 | -5.93 |
Interest & Investment Income | 11.22 | 16.25 | 20.17 | 1.11 | 0.06 | 2.58 |
Pretax Income | 443.04 | 390.92 | 350.22 | 246.2 | 148.98 | 165.6 |
Income Tax Expense | 91.03 | 68.73 | 61.6 | 40.71 | 19.73 | 20.9 |
Earnings From Continuing Operations | 352.01 | 322.19 | 288.62 | 205.49 | 129.26 | 144.69 |
Minority Interest in Earnings | -0.45 | - | - | - | - | - |
Net Income | 351.56 | 322.19 | 288.62 | 205.49 | 129.26 | 144.69 |
Net Income to Common | 351.56 | 322.19 | 288.62 | 205.49 | 129.26 | 144.69 |
Net Income Growth | 16.65% | 11.63% | 40.45% | 58.98% | -10.67% | 342.97% |
Shares Outstanding (Basic) | 220 | 220 | 220 | 170 | 160 | 160 |
Shares Outstanding (Diluted) | 220 | 220 | 220 | 170 | 160 | 160 |
Shares Change (YoY) | - | - | 29.64% | 6.06% | - | 202.12% |
EPS (Basic) | 1.60 | 1.46 | 1.31 | 1.21 | 0.81 | 0.90 |
EPS (Diluted) | 1.60 | 1.46 | 1.31 | 1.21 | 0.81 | 0.90 |
EPS Growth | 16.65% | 11.63% | 8.34% | 49.89% | -10.67% | 46.62% |
Free Cash Flow | 266.99 | -19.7 | 19.39 | 182.17 | 165.64 | 99.93 |
Free Cash Flow Per Share | 1.21 | -0.09 | 0.09 | 1.07 | 1.03 | 0.63 |
Dividend Per Share | 1.450 | 1.400 | 1.300 | 0.500 | 0.356 | 0.300 |
Dividend Growth | 3.57% | 7.69% | 160.00% | 40.33% | 18.77% | -7.69% |
Gross Margin | 51.21% | 51.71% | 54.05% | 56.31% | 58.82% | 59.37% |
Operating Margin | 13.51% | 13.36% | 15.10% | 15.60% | 16.13% | 16.89% |
Profit Margin | 10.38% | 10.80% | 12.63% | 12.54% | 13.61% | 14.46% |
Free Cash Flow Margin | 7.89% | -0.66% | 0.85% | 11.11% | 17.44% | 9.99% |
EBITDA | 545.77 | 553.05 | 539.76 | 329 | 205.17 | 210.04 |
EBITDA Margin | 16.12% | 18.54% | 23.62% | 20.07% | 21.60% | 20.99% |
D&A For EBITDA | 88.23 | 154.47 | 194.61 | 73.26 | 51.93 | 41.1 |
EBIT | 457.54 | 398.58 | 345.16 | 255.75 | 153.24 | 168.94 |
EBIT Margin | 13.51% | 13.36% | 15.10% | 15.60% | 16.13% | 16.89% |
Effective Tax Rate | 20.55% | 17.58% | 17.59% | 16.54% | 13.24% | 12.62% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.